These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 1582884)
1. Enhanced tumor localization of monoclonal antibody by treatment with kininase II inhibitor and angiotensin II. Noguchi A; Takahashi T; Yamaguchi T; Kitamura K; Noguchi A; Tsurumi H; Takashina K; Maeda H Jpn J Cancer Res; 1992 Mar; 83(3):240-3. PubMed ID: 1582884 [TBL] [Abstract][Full Text] [Related]
2. Persistent distension and enhanced diffusive extravasation of tumor vessels improved uniform tumor targeting of radioimmunoconjugate in mice administered with angiotensin II and kininase inhibitor. Kinuya S; Yokoyama K; Yamamoto W; Kawashima A; Konishi S; Hiramatsu T; Tega H; Shuke N; Aburano T; Watanabe N; Takayama T; Michigishi T; Tonami N Oncol Res; 1998; 10(11-12):551-9. PubMed ID: 10367936 [TBL] [Abstract][Full Text] [Related]
3. Pharmacologic intervention with angiotensin II and kininase inhibitor enhanced efficacy of radioimmunotherapy in human colon cancer xenografts. Kinuya S; Yokoyama K; Kawashima A; Hiramatsu T; Konishi S; Shuke N; Watanabe N; Takayama T; Michigishi T; Tonami N J Nucl Med; 2000 Jul; 41(7):1244-9. PubMed ID: 10914917 [TBL] [Abstract][Full Text] [Related]
4. Enhanced effects of monoclonal antibody carboplatin immunoconjugates uptake and anti-tumor effects with angiotensin II and tumor necrosis factor. Takeda A; Miyoshi T; Shimada H; Ochiai T; Isono K J Chemother; 1999 Apr; 11(2):137-43. PubMed ID: 10326745 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and specificity of a monoclonal antibody-drug conjugate in chemotherapy by intratumoral injection. Kitamura K; Takahashi T; Miyagaki T; Yamaoka N; Tsurumi H; Ohtsuji E; Kamiguchi M; Noguchi A; Yamaguchi T Jpn J Cancer Res; 1992 Jul; 83(7):769-74. PubMed ID: 1387634 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of angiotensin II activity enhanced the antitumor effect of cyclooxygenase-2 inhibitors via insulin-like growth factor I receptor pathway. Yasumaru M; Tsuji S; Tsujii M; Irie T; Komori M; Kimura A; Nishida T; Kakiuchi Y; Kawai N; Murata H; Horimoto M; Sasaki Y; Hayashi N; Kawano S; Hori M Cancer Res; 2003 Oct; 63(20):6726-34. PubMed ID: 14583467 [TBL] [Abstract][Full Text] [Related]
7. Tumor localization and in vivo antitumor activity of the immunoconjugate composed of anti-human colon cancer monoclonal antibody and mitomycin C-dextran conjugate. Noguchi A; Takahashi T; Yamaguchi T; Kitamura K; Takakura Y; Hashida M; Sezaki H Jpn J Cancer Res; 1991 Feb; 82(2):219-26. PubMed ID: 1706329 [TBL] [Abstract][Full Text] [Related]
8. Local administration of monoclonal antibody-drug conjugate: a new strategy to reduce the local recurrence of colorectal cancer. Kitamura K; Takahashi T; Kotani T; Miyagaki T; Yamaoka N; Tsurumi H; Noguchi A; Yamaguchi T Cancer Res; 1992 Nov; 52(22):6323-8. PubMed ID: 1423277 [TBL] [Abstract][Full Text] [Related]
9. Radioimmunodetection of human colon cancer in nude mice by a new monoclonal antibody A7 against human colorectal cancer. Kojima S; Shimura N; Kubodera A; Kubota K; Takahashi T; Oyamada H Int J Rad Appl Instrum B; 1991; 18(8):847-53. PubMed ID: 1800460 [TBL] [Abstract][Full Text] [Related]
10. Differences between A7 antibody and anti-CEA antibody. Kojima S; Suzuki N; Kubota K; Shimura N; Kubodera A; Yamaguchi T; Takahashi T; Oyamada H Nucl Med Biol; 1993 Feb; 20(2):197-202. PubMed ID: 8383559 [TBL] [Abstract][Full Text] [Related]
11. Radioimmunodetection of human colon cancer using 99mTc-MDP-MoAb-A7 in mice. Shimura N; Kojima S; Kubodera A; Kubota K; Takahashi T; Oyamada H Int J Rad Appl Instrum B; 1992 Jan; 19(1):105-9. PubMed ID: 1577609 [TBL] [Abstract][Full Text] [Related]
12. [Enhancing effect by anti-cancer drugs on growth inhibition of colon carcinoma in nude mice by monoclonal antibody and complement]. Sakita M; Hata K; Iwamoto A; Kitamura K; Suzuyama H; Takahashi T Nihon Gan Chiryo Gakkai Shi; 1989 May; 24(5):999-1006. PubMed ID: 2778387 [TBL] [Abstract][Full Text] [Related]
13. Angiotensin II inhibition attenuates postexercise proteinuria in rats. Gündüz F; Kuru O; Sentürk UK Int J Sports Med; 2005 Nov; 26(9):710-3. PubMed ID: 16237614 [TBL] [Abstract][Full Text] [Related]
16. [Comparative studies of 111In-labeled monoclonal antibody using spacer-containing and non-spacer bifunctional chelates: (II). Biodistribution, metabolism and excretion in vivo]. Sun B Kaku Igaku; 1994 May; 31(5):473-87. PubMed ID: 8028219 [TBL] [Abstract][Full Text] [Related]
17. Potential usefulness of 99mTc-labeled monoclonal antibody A7 for immunoscintigraphy of human pancreatic carcinoma. Matsumura H; Otsuji E; Kobayashi S; Okamoto K; Toma A; Yamagishi H Anticancer Res; 2001; 21(5):3433-7. PubMed ID: 11848505 [TBL] [Abstract][Full Text] [Related]
18. Synergistic actions of enalapril and tempol during chronic angiotensin II-induced hypertension. Elmarakby AA; Williams JM; Imig JD; Pollock JS; Pollock DM Vascul Pharmacol; 2007 Feb; 46(2):144-51. PubMed ID: 17112788 [TBL] [Abstract][Full Text] [Related]
19. Mechanism of action of enalapril in experimental hypertension and acute left ventricular failure. Sweet CS; Gaul SL; Reitz PM; Blaine EH; Ribeiro LT J Hypertens Suppl; 1983 Oct; 1(1):53-63. PubMed ID: 6100609 [TBL] [Abstract][Full Text] [Related]
20. Effects of captopril and enalapril on sodium excretion and blood pressure in sodium-deficient dogs. McCaa RE; Gillespie JB Fed Proc; 1984 Apr; 43(5):1336-41. PubMed ID: 6323226 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]